Cargando…
Exenatide inhibits NF-κB and attenuates ER stress in diabetic cardiomyocyte models
Exenatide is used to treat patients with type-2 diabetes and it also exerts cardioprotective effects. Here, we tested whether Exenatide attenuates hyperglycemia-related cardiomyocyte damage by inhibiting endoplasmic reticulum (ER) stress and the NF-κB signaling pathway. Our results demonstrated that...
Autores principales: | Fu, Zhenhong, Mui, David, Zhu, Hang, Zhang, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7244034/ https://www.ncbi.nlm.nih.gov/pubmed/32392536 http://dx.doi.org/10.18632/aging.103181 |
Ejemplares similares
-
Alprostadil attenuates LPS-induced cardiomyocyte injury by inhibiting the Wnt5a/JNK/NF-κB pathway
por: Yu, T., et al.
Publicado: (2019) -
NF-κB p65 Attenuates Cardiomyocyte PGC-1α Expression in Hypoxia
por: Rabinovich-Nikitin, Inna, et al.
Publicado: (2022) -
Exenatide Protects Against Cardiac Dysfunction by Attenuating Oxidative Stress in the Diabetic Mouse Heart
por: Ding, Wei, et al.
Publicado: (2019) -
Naringin attenuates diabetic retinopathy by inhibiting inflammation, oxidative stress and NF-κB activation in vivo and in vitro
por: Liu, Lihua, et al.
Publicado: (2017) -
Exenatide can inhibit calcification of human VSMCs through the NF-kappaB/RANKL signaling pathway
por: Zhan, Jun-Kun, et al.
Publicado: (2014)